Hobart Private Capital, LLC Stryker Corp Transaction History

Hobart Private Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Mar 11, 2024	SELL	$126.5 - $225.1 $289,179 - $514,578	-2,286 Closed	0 $0
Q4 2019 Mar 11, 2024	BUY	$197.98 - $220.53 $452,582 - $504,131	2,286 New	2,286 $480 Million
Q3 2019 Mar 11, 2024	BUY	$205.4 - $221.82 $9,859 - $10,647	48 Added 2.45%	2,011 $435 Million
Q2 2019 Mar 11, 2024	BUY	$180.24 - $205.58 $27,937 - $31,864	155 Added 8.57%	1,963 $403 Million
Q1 2019 Mar 11, 2024	SELL	$152.46 - $198.0 $9,452 - $12,276	-62 Reduced 3.32%	1,808 $357 Million
Q4 2018 Mar 11, 2024	BUY	$145.0 - $178.65 $36,395 - $44,841	251 Added 15.5%	1,870 $293 Million
Q3 2018 Mar 11, 2024	BUY	$163.25 - $177.68 $40,975 - $44,597	251 Added 18.35%	1,619 $288 Million
Q2 2018 Mar 11, 2024	BUY	$155.17 - $179.78 $212,272 - $245,939	1,368 New	1,368 $231 Million

2,160

285M

1.13M

1.1M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $133B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.